Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
This book discusses the most recent evidence-based approach to hematological diagnosis and management in ICU. It elaborates on the hematological problems in critical care setup, from hematological malignancies to post-operative management of bone marrow transplants. The book also covers the interpretation of laboratory abnormalities, administration of various chemotherapeutic agents, and critical care management of various primary and secondary hematological issues. It explains how to handle different complications in the intensive care unit. Various coagulation tests and their interpretations, particularly point-of-care tests such as thromboelastography and ROTEM are also focused on.
Critical Care Hematology will benefit practitioners and trainees in hematology and critical care medicine. The book's comprehensive coverage will provide readers with a holistic view of the appropriate approaches to hematology in the ICU. Also, the chapters provide a systematic approach to diagnosing and flowcharts to assist medical practitioners in making timely decisions amid their hectic duties.
Prof. Dr. Shakti Bedanta Mishra graduated from Medical College, Kolkata, in 2006. He completed his MD degree in Anesthesiology from SCB Medical College Cuttack in 2011. He subsequently finished his DM degree from SGPGIMS Lucknow in 2016 and was awarded the best DM resident of SGPGIMS during his tenure there. He joined IMS and SUM hospital as an assistant professor in 2016 and started the Department of Critical Care Medicine and DM course in 2018. He became a Professor in 2021. He was awarded the best abstract award in 2017 by the European Society of Critical Care Medicine 2017 and as Intensivist of the year award in 2015 by the Indian Society of Critical Care Medicine.
Part I Diagnostic Foundations.- 1. Guide to Simplified CBC and Peripheral Smear Analysis.- 2. Bone Marrow Biopsy in ICU.- 3. Abnormal Clotting Profile.- Part II Hematological Abnormalities and Management in ICU.- 4. Approach to Anemia in ICU.- 5. Leukopenia in ICU.- 6. Approach to Thrombocytopenia in ICU.- 7. Pediatric Hemolysis.- 8. Approach to Thrombocytopenia (Pediatric Patients).- 9. Heparin-Induced Thrombocytopenia.- 10. Patients on Anticoagulants.- 11. Arterial & Venous Thrombosis Patients.- 12. Sickle Cell Crisis.- Part III Transfusion Medicine in ICU.- 13. Blood Components & Their Contents.- 14. POC Guided Transfusion of Blood Products in ICU.- 15. Transfusion Reactions in ICU.- 16. Management of Patients with Massive Transfusion.- Part IV Oncological Emergencies and Critical Care.- 17. Hyperviscosity in Plasma Cell Dyscrasias.- 18. Disseminated Intravascular Coagulation (DIC).- 19. Diagnosis and Management of Thrombotic Microangiopathies.- 20. Leukostasis: A Comprehensive Overview.- 21. Tumor Lysis Syndrome.- 22. Hypercalcemia of Malignancy.- 23. Advancements in Chemotherapeutic Drugs for Intensive Care Management of Hematological Malignancies.- 24. Comprehensive ICU Management of Chemotherapy for Hematological Malignancies.- 25. Hematopoietic Stem Cell Transplantations (HSCT) and Implications in Critically Ill.- 26. Patients on CAR-T Cell Therapy.- Part V Infections in Hematological Patients.- 27. Opportunistic Infections in Hematological Malignancies.- 28. Febrile Neutropenic Patients in Hematological Malignancies.- 29. Invasive Fungal Infection in Hematological Malignancies.- Part VI Critical Care Pathways and Prognosis.- 30. Early Care of Unstable Hematological Malignancies Patients: Preventing Admission into ICU.- 31. Decision for Intensity of Treatment for Onco-Patients after ICU Admission.- 32. Assessing Goals of Care in ICU with Short-term & Long-term Outcomes in Hematological Malignancies.- 33. Management of Post-operative Bleeding Patients.- 34. Acute Respiratory Failure in Hematological Malignancies.- 35. End-of-Life Care & Palliative Care of Hematological Malignancies.
